Crystalvue Medical Co Ltd

Crystalvue Medical Co Ltd

TTPEX:6527
71.50
TWD
-0.50
(-0.69%)
5.96EPS
12.39P/E
1.90BMarket Cap
Mar 24Next Earn
Crystalvue Medical Co Ltd
TPEX:6527
(Taipei Exchange)

Recent

price

71.50

P/E

ratio

12.39

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
- -
18.63
18.07
20.74
24.11
21.95
27.08
29.47
19.88
28.8
31.76
32.9
34.3
37.45
35.29
Revenue per Share
- -
1.55
1.91
2.28
2.21
1.49
3.12
4.06
2.23
3.08
4.59
4.13
5.02
5.8
6.05
Basic EPS, GAAP
- -
0.2
2.52
-0.05
2.56
1.89
3.36
4.08
-0.79
-11.52
1.71
5.81
0.83
-1.82
-0.08
Free Cash Flow per Basic Share
- -
- -
- -
0.33
1.14
0.95
0.96
1.62
2.44
1.33
1.85
2.27
2.07
2.25
- -
Dividend per Share
11.13
12.97
14.84
17.13
18.19
18.73
20.57
27.52
26.94
28.69
31.23
33.92
37.21
40.58
42.26
Book Value per Share
10.72
12.76
14.79
17.07
18.15
18.7
20.54
27.48
24.17
28.65
31.16
33.73
37.05
40.48
42.22
Tangible Book Value per Share
22
22
22
22
22
22
22
22
25
25
25
25
25
25
25
Basic Weighted Avg Shares
- -
404
398
465
542
494
606
661
504
722
795
824
868
949
895
Sales/Revenue/Turnover
- -
8.09
9.78
12.04
10.48
7.49
12.73
17.25
11.43
12.26
15.69
14.28
16.71
19.07
20.21
Operating Margin (%)
- -
12
11
8
10
10
12
20
25
41
26
29
29
18
13
Depreciation Expense
- -
34
42
51
50
34
70
91
57
77
115
103
127
147
153
Net Income, GAAP
- -
17.36
22.21
19.01
19.78
9.23
13.02
18.49
10.08
29.25
19.24
13.65
20.22
17.89
19.1
Effective Tax Rate (%)
- -
8.33
10.56
11.01
9.15
6.8
11.53
13.78
11.23
10.7
14.46
12.55
14.65
15.49
17.15
Profit Margin (%)
203
267
314
357
378
386
415
657
550
330
400
495
467
380
359
Working Capital
- -
- -
- -
- -
- -
- -
- -
44
38
31
25
19
12
5
90
LT Debt
250
292
334
385
409
421
462
702
675
719
776
857
939
1,028
1,071
Total Equity
- -
9.97
9.69
12.61
11.48
8.09
15.2
15.33
7.05
8.49
12.89
12.03
12.41
14.47
- -
Return on Invested Capital (%)
- -
12.43
13.45
14.24
12.49
8.09
15.83
15.22
7.87
10.58
14.82
12.33
13.88
14.76
- -
Return on Capital (%)
- -
12.43
13.45
14.24
12.49
8.09
15.83
15.66
8.23
11.08
15.39
12.67
14.16
14.94
- -
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
7
7
7
LT Borrowings
- -
30
90
LT Finance Leases
3
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
25
25
Market Capitalization
1,792
1,853
1,901

Working Capital

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
597
591
578
Cash, Cash Equivalents & STI
110
84
104
Accounts Receivable, Net
150
158
141
Inventories
323
335
306
Total Current Liabilities
341
292
220
Payables & Accruals
- -
- -
- -
ST Debt
7
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.09%
8.79%
9.59%
Free Cash Flow
-477.18%
212.75%
-319.18%
Net Income, GAAP
17.89%
22.76%
15.59%
Sales/Revenue/Turnover
8.74%
14.31%
9.33%
Total Cash Common Dividend
- -
3.26%
9.03%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
200
211
233
224
868
2025
224
256
- -
267
949
2026
188
218
221
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.24
1.28
1.33
1.18
5.02
2025
1.46
1.49
- -
1.49
5.8
2026
1.33
1.67
1.56
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2.07
2025
- -
- -
- -
- -
2.25
2026
- -
- -
- -
- -
- -
Business
Crystalvue Medical Corporation develops, produces, and distributes sophisticated ophthalmic diagnostic instruments across the globe. Established in 2009, the company specializes in a range of devices including advanced retinal cameras, optical coherence tomography (OCT) systems, tonometers, and automated lens edgers and tracers. Crystalvue also provides services for original design and equipment manufacturing, along with supplying endoscopic medical instruments. Their operations are headquartered in Taoyuan City, Taiwan, serving a worldwide clientele.